Page last updated: 2024-08-23
deoxynivalenol and Hepatocellular Carcinoma
deoxynivalenol has been researched along with Hepatocellular Carcinoma in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Abdul, NS; Chuturgoon, AA; Ghazi, T; Nagiah, S; Ndlovu, S | 1 |
Didier, A; Dietrich, R; Lippke, H; Märtlbauer, E; Nielsen, C | 1 |
Other Studies
2 other study(ies) available for deoxynivalenol and Hepatocellular Carcinoma
Article | Year |
---|---|
Deoxynivalenol downregulates NRF2-induced cytoprotective response in human hepatocellular carcinoma (HepG2) cells.
Topics: Antioxidants; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Liver Neoplasms; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Trichothecenes | 2021 |
Potential of deoxynivalenol to induce transcription factors in human hepatoma cells.
Topics: Activating Transcription Factor 3; Carcinoma, Hepatocellular; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Gene Expression Profiling; Humans; Liver Neoplasms; MAP Kinase Signaling System; Mycotoxins; Transcription Factors; Trichothecenes | 2009 |